Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Digestion|January 21, 2016
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's DiseaseKenichiro Takahashi, Atsushi Nishida, Takehide Fujimoto, et al.
Experimental and Therapeutic Medicine|September 15, 2012
Interleukin-28B polymorphisms are associated with an early viral response in patients receiving hepatitis C therapyRie Osaki, Takashi Nishimura, Takayuki Takeuchi, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2015
Familial and multiple gastrointestinal stromal tumors with fair response to a half-dose of imatinibShigeki Bamba, Seiichi Hirota, Osamu Inatomi, et al.
Experimental and Therapeutic Medicine|July 23, 2016
Prognostic factors affecting early colectomy in patients with moderate to severe ulcerative colitis treated with calcineurin inhibitorsHiromitsu Ban, Shigeki Bamba, Atsushi Nishida, et al.
Journal of Gastrointestinal Cancer|May 24, 2012
Magnified endoscopy combined with narrow band imaging of minimal superficial esophageal neoplasia-indicators to differentiate intraepithelial neoplasiasYosuke Mochizuki, Yasuharu Saito, Ayako Kobori, et al.
Experimental and Therapeutic Medicine|October 13, 2012
Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitorsShigeki Bamba, Akira Andoh, Hirotsugu Imaeda, et al.
Digestive Diseases and Sciences|September 9, 2011
The severity of dextran sodium sulfate-induced colitis can differ between dextran sodium sulfate preparations of the same molecular weight rangeShigeki Bamba, Akira Andoh, Hiromitsu Ban, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 26, 2015
[Cases of Three Patients with Gastric Cancer and Metastasis to the Skeletal Muscle]Yoshihiko Sugitani, Osamu Inatomi, Rie Tanabe, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Efficacy and safety of nivolumab and ipilimumab with or without chemotherapy for unresectable non-small cell lung cancer: a multicenter retrospective observational studyToshiyuki Sumi, Yutaro Nagano, Keiki Yokoo, et al.
Japanese Journal of Clinical Oncology|May 7, 2025
Efficacy of nivolumab + ipilimumab ± chemotherapy versus pembrolizumab + chemotherapy in patients with PD-L1-negative non-small cell lung cancer (START001 PART-B): a multicenter retrospective observational studyYutaro Nagano, Mamoru Takahashi, Toshiyuki Sumi, et al.
Pageof 4